- Home
- RCUS vs PTON Comparison
RCUS vs PTON Comparison
Compare RCUS & PTON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RCUS | PTON |
|---|---|---|
| Founded | 2015 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Recreational Games/Products/Toys |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.1B | 2.7B |
| IPO Year | 2018 | 2019 |
Fundamental Metrics
Financial Performance| Metric | RCUS | PTON |
|---|---|---|
| Price | $21.31 | $6.38 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 8 | 13 |
| Target Price | ★ $29.38 | $9.68 |
| AVG Volume (30 Days) | 2.1M | ★ 8.3M |
| Earning Date | 10-28-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $240,000,000.00 | ★ $2,455,600,000.00 |
| Revenue This Year | N/A | $1.53 |
| Revenue Next Year | N/A | $1.42 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $6.50 | $4.63 |
| 52 Week High | $26.40 | $10.90 |
Technical Indicators
Market Signals| Indicator | RCUS | PTON |
|---|---|---|
| Relative Strength Index (RSI) | 41.72 | 39.97 |
| Support Level | $20.35 | $6.31 |
| Resistance Level | $26.10 | $6.90 |
| Average True Range (ATR) | 1.48 | 0.30 |
| MACD | -0.61 | 0.02 |
| Stochastic Oscillator | 15.21 | 19.85 |
Price Performance
Historical ComparisonAbout RCUS Arcus Biosciences Inc.
Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.
About PTON Peloton Interactive Inc.
Peloton Interactive Inc operates an interactive fitness platform. It operates its business in two reportable segments: Connected Fitness Products and Subscription. Connected Fitness Product derives revenue from the portfolio of Connected Fitness Products and related accessories, as well as Precor-branded fitness products, delivery and installation services, Peloton Bike portfolio rental products, extended warranty agreements, branded apparel, and commercial service contracts. Subscription revenue is derived from monthly Subscription fees. The company generates maximum revenue from the Subscription segment. Geographically, the company derives a majority of its revenue from North America and the rest from International markets.